| 英文别名： |
Cefmenoxime hydrochloride;8-[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyimino-acetyl]amino-4-[(1-methyltetrazol-5-yl)sulfanylmethyl]-7-oxo-2-thia-6-azabicyclo[4.2.0]oct-4-ene-5-carboxylic acid hydrochloride (2:1);Apacef;Apatef;Cefmenoxime hemihydrochloride;CEFOTETAN;Cefotetan (500 mg);Cefotetan acid;CEFOTETAN SODIUM;Ceftenon;Cepan Darvilen;SCE-1365 hemihydrochloride;Yamatetan;Cefmenoxime HCl;Cefmax;NON736D32W;Abbott 50192 (HCl);AB 50912 hemihydrochloride;SCE 1365 hydrochloride;Bestcall (TN);(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid 7(sup 2)-(Z)-(O-methyloxime), hydrochloride (2:1);Cefmenoxime hydrochloride [USAN:USP:JAN];NCGC00;Cefmenoxime Hydrochloride (2:1);Tacef;CEFMENOXIME HYDROCHLORIDE [MART.];(6R,7R)-7-(((2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)sulfanyl)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid hydrochloride (2:1);5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 7-(((2-AMINO-4-THIAZOLYL)(METHOXYIMINO)ACETYL)AMINO)-3-(((1-METHYL-1H-TETRAZOL-5-YL)THIO)METHYL)-8-OXO-, HYDROCHLORIDE (2:1), (6R-(6.ALPHA.,7.BETA.(Z)));(6R,7R)-7-[[(2E)-2-(2-Amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;hydrochloride;5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, hydrochloride (2:1), (6R-(6alpha,7beta(Z)))-;CEFMENOXIME HYDROCHLORIDE [ORANGE BOOK];ABBOTT-50192 (HCL);Abbott-50192;7beta-(((2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)sulfanyl)methyl)-3,4-didehydropenam-4-carboxylic acid hydrochloride (2:1);CCG-270623;CEFMENOXIME HYDROCHLORIDE [WHO-DD];(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;hydrochloride;s4647;AKOS040733637;Cefmenoxime hydrochloride (JP17/USP);EINECS 278-299-4;CEFMENOXIME HYDROCHLORIDE [JAN];CEFMENOXIME HYDROCHLORIDE [USP IMPURITY];C-2471;(6R,7R)-7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrochloride(2:1);5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 7-(((2-AMINO-4-THIAZOLYL)(METHOXYIMINO)ACETYL)AMINO)-3-(((1-METHYL-1H-TETRAZOL-5-YL)THIO)METHYL)-8-OXO-, HYDROCHLORIDE (2:1), (6R-(6alpha,7beta(Z)));Cefmenoxime hydrochloride (USAN:USP:JAN);(6R,7R)-7-((Z)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetylamino)-3-(1-methyl-1H-tetrazol-5-ylsulfanylmethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid hemihydrochlori... |
沪公网安备 
